Evidence map›Paper›PMID 41011611›Full record

ReviewMolecules (Basel, Switzerland)2025

Ferulic Acid: Mechanistic Insights and Multifaceted Applications in Metabolic Syndrome, Food Preservation, and Cosmetics.

Daniel A Jacobo-Velázquez

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. The Inclusion of Supercritical Fluid Extract ofAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Unlocking the Potential ofFoods (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Daniel A Jacobo-VelázquezTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Campus Monterrey, Av. Eugenio Garza Sada 2501 Sur, Monterrey 64849, NL, Mexico.ORCID 0000-0002-9478-2570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferulic acid (FA) is a plant-derived phenolic compound recognized for its potent antioxidant and anti-inflammatory properties, with growing applications in health, food, and cosmetic sciences. This review presents a comprehensive overview of recent in vivo and clinical evidence, emphasizing its effects on metabolic syndrome (MetS) and its technological applications in food and cosmetics. FA has shown preventive and therapeutic potential in managing MetS by improving glucose and lipid metabolism, lowering blood pressure, reducing oxidative stress, and modulating inflammatory and microbiota-related pathways. In food systems, FA serves as a multifunctional additive, exhibiting antimicrobial activity, inhibition of lipid oxidation, stabilization of pigments, and protection of sensitive nutrients that extend shelf life and enhance nutritional quality. Its inclusion in cosmetic formulations further demonstrates synergistic photoprotective effects with conventional UV filters, antioxidant support for vitamins C and E, and anti-aging and skin-brightening properties, although formulation challenges remain. Collectively, FA's pleiotropic actions and compatibility with clean-label trends highlight its value as a natural bioactive. Continued research on improving its stability, bioavailability, and clinical validation will support its broader integration into functional food, nutraceutical, and cosmeceutical products.

Indexed as

CosmeticsCoumaric AcidsFood PreservationMetabolic SyndromeAnimalsAnti-Inflammatory AgentsAntioxidantsHumansAnti-Inflammatory AgentsAntioxidantsCosmeticsCoumaric Acidsferulic acidantioxidantcosmeceuticalsferulic acidfood additivelipid oxidationmetabolic syndromenatural preservativenutraceuticalpolyphenolsprebiotic

Identifiers

PMID41011611
PMCPMC12472962

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.